Skip to content

A single-center non-blinded randomized controlled trial on the effect of ovarian hyperstimulation on endometrial receptivity.

A single-center non-blinded randomized controlled trial on the effect of ovarian hyperstimulation on endometrial receptivity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24197
Enrollment
193
Registered
2011-12-09
Start date
2013-01-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subfertility or infertility

Interventions

Ovarian hyperstimulation, oocyte retrieval and oocyte fertilization will be performed using standard procedures. In the control arm, one or two fresh embryo(s) will be transferred in the same cycle w

Sponsors

Zorgonderzoek Nederland (ZonMw)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subfertile couples with female age <43 undergoing IVF (in vitro fertilization) or ICSI (intracytoplasmatic sperm injection).

Exclusion criteria

Exclusion criteria: 1. Couples undergoing a PGD cycle; 2. Couples for which IVF/ICSI is used to prevent the transmission of HIV; 3. Couples undergoing a modified natural cycle; 5. Women with borderline or invasive ovarian cancer; 6. Women with contraindications for IVF/ICSI treatment such as cardiovascular-pulmonary disease, severe diabetes, bleeding disorders, immunodeficiency and morbid obesity; 7. Women with premature ovarian failure; 8. Women with severe psychopathology, severe anxiety and inability to cope with treatment; 9. Not able or willing to provide informed consent.

Design outcomes

Primary

MeasureTime frame
Primary outcome measure will be cumulative ongoing pregnancy rate per cycle after twelve months of treatment.

Secondary

MeasureTime frame
Secondary outcome measures will be embryo quality, clinical pregnancy rate, miscarriage rate, live birth rate, time to pregnancy, birth weight and percentage of children with congenital abnormalities.

Contacts

Public ContactFemke Mol

Center for Reproductive Medicine, Amsterdam University Medical Center / University of Amsterdam Room Q3-119; Meibergdreef 9, Amsterdam The Netherlands

f.mol@amsterdamumc.nl+31 (0)20 556 63557

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)